Information Provided By: 
Fly News Breaks for July 24, 2018
AYX
Jul 24, 2018 | 07:41 EDT
DA Davidson analyst Rishi Jaluria initiated Alteryx with a Neutral rating and a price target of $42. The analyst is positive on the company's "strong value proposition" that helps business users "blend together and analyze data from multiple sources without needing a dedicated data scientist" as well as its attractive financial model of revenue growth and operating leverage. However, Jaluria also cites the 97% runup in the stock price over the past year and believes that shares are fully valued.
News For AYX From the Last 2 Days
AYX
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
